CS logo
small CS logo
Medical Research South

Charleston, South Carolina, United States
Doctor in Goose Creek, South Carolina
110b Springhall Dr, Goose Creek, SC 29445

About Medical Research South


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
NuSirt Biopharma
3
Boehringer Ingelheim
2
Eli Lilly and Company
2
Seqirus
2
Abbott Nutrition
1
AstraZeneca
1
InteKrin Therapeutics, Inc.
1
Mereo BioPharma
1
Novartis
1
Novartis Pharmaceuticals
1
Pfizer
1
Total Rows: 15

Clinical Trials at Medical Research South


During the past decade, Medical Research South conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 13 clinical trials were completed, i.e. on average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years55222211110000223333Started TrialsCompleted Trails201520162017201820190246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
2006-07-01
2007-03-01
Completed
A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
2008-02-01
2009-09-01
Completed
367
A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension
2008-12-22
2009-10-13
Completed
155
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.
2010-03-01
2011-10-01
Completed
226
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
2010-04-15
2012-03-21
Terminated
27
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
2010-10-01
2013-02-01
Completed
2,245
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
2014-07-01
2016-01-01
Completed
96
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
2014-07-25
2017-05-18
Completed
166

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Medical Research South" #1 sponsor was "NuSirt Biopharma" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Seqirus" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Research South" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Great Lakes Drug Development, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNuSirt Biopharma: 3NuSirt Biopharma: 3Boehringer Ingelheim: 2Boehringer Ingelheim: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Seqirus: 2Seqirus: 2Abbott Nutrition: 1Abbott Nutrition: 1AstraZeneca: 1AstraZeneca: 1InteKrin Therapeutics, Inc.: 1InteKrin Therapeutics, Inc.: 1Mereo BioPharma: 1Mereo BioPharma: 1Novartis: 1Novartis: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsBiomedical AdvancedResearch andDevelopment Authority:2Biomedical AdvancedResearch andDevelopment Authority:2CoLucid Pharmaceuticals: 2CoLucid Pharmaceuticals: 2Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Great Lakes DrugDevelopment, Inc.: 1Great Lakes DrugDevelopment, Inc.: 1Integrium: 1Integrium: 1Novartis: 1Novartis: 1

Clinical Trials Conditions at Medical Research South


According to Clinical.Site data, the most researched conditions in "Medical Research South" are "Hypertension" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Acute Coronary Syndrome" (1 trials), "Acute Gout" (1 trials) and "Acute Migraine" (1 trials). Many other conditions were trialed in "Medical Research South" in a lesser frequency.

Clinical Trials Intervention Types at Medical Research South


Most popular intervention types in "Medical Research South" are "Drug" (16 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "High Metformin" (2 trials), "Low Metformin" (2 trials), "Metformin" (2 trials) and "Mid Metformin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Medical Research South


The vast majority of trials in "Medical Research South" are 18 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Medical Research South


Currently, there are NaN active trials in "Medical Research South". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Medical Research South, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medical Research South, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 7Phase 2: 7Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 19Completed: 19Terminated: 1Terminated: 1